Navidea President, Dr. Mark Pykett, to Participate in Panel Discussion on Companion Diagnostics at BIO CEO

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaecuticals (NYSE AMEX: NAVB) President, Dr. Mark Pykett, to Participate in Panel Discussion on Companion Diagnostics at BIO CEO on February 14, 2012 at 10:30 am ET.

Feed Date: 
February 13, 2012